Karin Cecilia Dahllöf

Karin Cecilia Dahllöf

Chief Executive Officer chez MONIVENT AB

65 ans
Health Technology
Consumer Services

Profil

Karin Cecilia Dahllöf is currently the Chief Executive Officer at Monivent AB, an Independent Director at Boule Diagnostics AB and Bio Vitos Pharma AB, and a Director at Histolab Products AB.
Previously, she worked as a Director-Special Projects at HemoCue AB, Director-Hematology Business Unit at EKF Diagnostics Holdings Plc, and Vice President-Sales & Marketing at CellaVision AB.
She completed her undergraduate degree at the University of Gothenburg.

Postes actifs de Karin Cecilia Dahllöf

SociétésPosteDébut
BOULE DIAGNOSTICS AB Director/Board Member 01/01/2015
MONIVENT AB Chief Executive Officer 01/11/2018
BIO VITOS PHARMA AB Director/Board Member 01/01/2018
Histolab Products AB Director/Board Member -
Tous les postes actifs de Karin Cecilia Dahllöf

Anciens postes connus de Karin Cecilia Dahllöf

SociétésPosteFin
EKF DIAGNOSTICS HOLDINGS PLC Corporate Officer/Principal -
Corporate Officer/Principal -
CELLAVISION AB Sales & Marketing -
Voir l'expérience en détail de Karin Cecilia Dahllöf

Formation de Karin Cecilia Dahllöf

University of Gothenburg Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Karin Cecilia Dahllöf

Relations

41

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées5
CELLAVISION AB

Health Technology

BOULE DIAGNOSTICS AB

Health Technology

EKF DIAGNOSTICS HOLDINGS PLC

Health Technology

BIO VITOS PHARMA AB

Health Technology

MONIVENT AB

Health Technology

Entreprise privées2

Health Technology

Histolab Products AB

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Karin Cecilia Dahllöf